Details of the Drug Reposition

General Information of This Drug (ID: DMI17NX)

• Drug Name: ART621 (DMI17NX)

Information on Drug Reposition of This Drug

2 Phase 1/2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Psoriasis vulgaris	DIS6M7AN	EA90	Phase 1/2	[1]
Rheumatoid arthritis	DISTSB4J	FA20	Phase 1/2	[1]

References

• [1] Emerging drugs for psoriasis. Expert Opin Emerg Drugs. 2009 Mar;14(1):145-63.